Susquehanna International Group, LLP Eye Point Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$8.16 - $22.89 $1.58 Million - $4.44 Million	-194,100 Reduced 73.49%	70,000 $609,000
Q1 2024 May 07, 2024	SELL	$19.93 - $29.71 $5.92 Million - $8.82 Million	-296,900 Reduced 52.92%	264,100 $5.46 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $2.26 Million - $9.56 Million	396,300 Added 240.62%	561,000 $13 Million
Q3 2023 Nov 14, 2023	BUY	$7.99 - $15.36 $1.01 Million - $1.94 Million	126,200 Added 327.79%	164,700 $1.32 Million
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $30,602 - $90,900	10,100 Added 35.56%	38,500 $334,000
Q1 2023 May 16, 2023	SELL	$2.28 - $5.04 $14,135 - $31,248	-6,200 Reduced 17.92%	28,400 $83,000
Q4 2022 Feb 14, 2023	SELL	$2.37 - $7.2 $93,615 - $284,400	-39,500 Reduced 53.31%	34,600 $121,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $487,200 - $778,400	-70,000 Reduced 48.58%	74,100 $586,000
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $226,200 - $396,552	-31,200 Reduced 17.8%	144,100 $1.13 Million
Q1 2022 May 16, 2022	BUY	$8.67 - $14.11 $659,787 - $1.07 Million	76,100 Added 76.71%	175,300 $2.13 Million
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $173,060 - $312,800	17,000 Added 20.68%	99,200 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $112,650 - $175,800	15,000 Added 22.32%	82,200 $857,000
Q2 2021 Aug 11, 2021	BUY	$8.69 - $11.08 $187,704 - $239,328	21,600 Added 47.37%	67,200 $604,000
Q1 2021 May 17, 2021	BUY	$8.89 - $14.92 $405,384 - $680,352	45,600 New	45,600 $463,000

163

58.2M

224K

1.41M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $272M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.